Healthy Life Agritec Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 22, 2025, 11:35 pm

Quick Insight

Healthy Life Agritec Ltd, operating in the milk and milk products industry, currently trades at a price of 55.6 with a market capitalization of 138 Cr. Despite a relatively high P/E ratio of 42.3, the company's ROE stands at 10.6% and ROCE at 13.2%, indicating a decent return on equity and capital employed. However, the low OPM of 4% and net profit margin of 3% raise concerns about operational efficiency and profitability. With reserves of 10 Cr and borrowings of ₹8Cr, the company's financial position appears stable, supported by a comfortable ICR of 12.96x. Investors should closely monitor the company's ability to improve operational margins and profitability to drive future growth and shareholder value.

Competitors of Healthy Life Agritec Ltd

All Competitor Stocks of Healthy Life Agritec Ltd

Quarterly Result

Last Updated: May 31, 2025, 5:43 am

Below is a detailed analysis of the quarterly data for Healthy Life Agritec Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 84.00 Cr.. The value appears to be declining and may need further review. It has decreased from 88.00 Cr. (Sep 2024) to 84.00 Cr., marking a decrease of 4.00 Cr..
• For Expenses, as of Mar 2025, the value is 81.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 86.00 Cr. (Sep 2024) to 81.00 Cr., marking a decrease of 5.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Sep 2024) to 3.00 Cr., marking an increase of 1.00 Cr..
• For OPM %, as of Mar 2025, the value is 4.00%. The value appears strong and on an upward trend. It has increased from 2.00% (Sep 2024) to 4.00%, marking an increase of 2.00%.
• For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
• For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
• For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Sep 2024) to 3.00 Cr., marking an increase of 1.00 Cr..
• For Tax %, as of Mar 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 25.00%.
• For Net Profit, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Sep 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.84. The value appears strong and on an upward trend. It has increased from 0.47 (Sep 2024) to 0.84, marking an increase of 0.37.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 3:13 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:07 pm

Below is a detailed analysis of the balance sheet data for Healthy Life Agritec Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2024) to 25.00 Cr., marking an increase of 3.00 Cr..
• For Reserves, as of Mar 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2024) to 10.00 Cr., marking an increase of 5.00 Cr..
• For Borrowings, as of Mar 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 3.00 Cr. (Mar 2024) to 8.00 Cr., marking an increase of 5.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.00 Cr. (Mar 2024) to 10.00 Cr., marking an increase of 6.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 52.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 34.00 Cr. (Mar 2024) to 52.00 Cr., marking an increase of 18.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 6.00 Cr., marking an increase of 4.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 47.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Mar 2024) to 47.00 Cr., marking an increase of 16.00 Cr..
• For Total Assets, as of Mar 2025, the value is 52.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Mar 2024) to 52.00 Cr., marking an increase of 18.00 Cr..

Notably, the Reserves (10.00 Cr.) exceed the Borrowings (8.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for Healthy Life Agritec Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 5. It has increased from 1.14 (Mar 24) to 1.31, marking an increase of 0.17.
• For Diluted EPS (Rs.), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 5. It has increased from 1.14 (Mar 24) to 1.35, marking an increase of 0.21.
• For Cash EPS (Rs.), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 3. It has increased from 1.21 (Mar 24) to 1.38, marking an increase of 0.17.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 13.85. It has increased from 12.23 (Mar 24) to 13.85, marking an increase of 1.62.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 13.85. It has increased from 12.23 (Mar 24) to 13.85, marking an increase of 1.62.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 69.27. It has increased from 60.40 (Mar 24) to 69.27, marking an increase of 8.87.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 1.97. This value is below the healthy minimum of 2. It has increased from 1.64 (Mar 24) to 1.97, marking an increase of 0.33.
• For PBIT / Share (Rs.), as of Mar 25, the value is 1.91. This value is within the healthy range. It has increased from 1.57 (Mar 24) to 1.91, marking an increase of 0.34.
• For PBT / Share (Rs.), as of Mar 25, the value is 1.75. This value is within the healthy range. It has increased from 1.52 (Mar 24) to 1.75, marking an increase of 0.23.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 2. It has increased from 1.14 (Mar 24) to 1.31, marking an increase of 0.17.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 2. It has increased from 1.14 (Mar 24) to 1.31, marking an increase of 0.17.
• For PBDIT Margin (%), as of Mar 25, the value is 2.84. This value is below the healthy minimum of 10. It has increased from 2.71 (Mar 24) to 2.84, marking an increase of 0.13.
• For PBIT Margin (%), as of Mar 25, the value is 2.75. This value is below the healthy minimum of 10. It has increased from 2.60 (Mar 24) to 2.75, marking an increase of 0.15.
• For PBT Margin (%), as of Mar 25, the value is 2.53. This value is below the healthy minimum of 10. It has increased from 2.51 (Mar 24) to 2.53, marking an increase of 0.02.
• For Net Profit Margin (%), as of Mar 25, the value is 1.89. This value is below the healthy minimum of 5. It has increased from 1.88 (Mar 24) to 1.89, marking an increase of 0.01.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.89. This value is below the healthy minimum of 8. It has increased from 1.88 (Mar 24) to 1.89, marking an increase of 0.01.
• For Return on Networth / Equity (%), as of Mar 25, the value is 9.47. This value is below the healthy minimum of 15. It has increased from 9.31 (Mar 24) to 9.47, marking an increase of 0.16.
• For Return on Capital Employeed (%), as of Mar 25, the value is 13.07. This value is within the healthy range. It has increased from 12.13 (Mar 24) to 13.07, marking an increase of 0.94.
• For Return On Assets (%), as of Mar 25, the value is 6.22. This value is within the healthy range. It has decreased from 7.44 (Mar 24) to 6.22, marking a decrease of 1.22.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.05.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.21. This value is within the healthy range. It has increased from 0.09 (Mar 24) to 0.21, marking an increase of 0.12.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 4.00. It has decreased from 4.36 (Mar 24) to 4.00, marking a decrease of 0.36.
• For Current Ratio (X), as of Mar 25, the value is 2.84. This value is within the healthy range. It has decreased from 6.20 (Mar 24) to 2.84, marking a decrease of 3.36.
• For Quick Ratio (X), as of Mar 25, the value is 2.33. This value exceeds the healthy maximum of 2. It has decreased from 5.34 (Mar 24) to 2.33, marking a decrease of 3.01.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 12.96. This value is within the healthy range. It has decreased from 30.72 (Mar 24) to 12.96, marking a decrease of 17.76.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.63. This value is within the healthy range. It has decreased from 22.31 (Mar 24) to 9.63, marking a decrease of 12.68.
• For Enterprise Value (Cr.), as of Mar 25, the value is 155.60. It has increased from 10.53 (Mar 24) to 155.60, marking an increase of 145.07.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has increased from 0.07 (Mar 24) to 0.90, marking an increase of 0.83.
• For EV / EBITDA (X), as of Mar 25, the value is 31.84. This value exceeds the healthy maximum of 15. It has increased from 2.91 (Mar 24) to 31.84, marking an increase of 28.93.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.06 (Mar 24) to 0.86, marking an increase of 0.80.
• For Price / BV (X), as of Mar 25, the value is 4.32. This value exceeds the healthy maximum of 3. It has increased from 0.31 (Mar 24) to 4.32, marking an increase of 4.01.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.06 (Mar 24) to 0.86, marking an increase of 0.80.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.29 (Mar 24) to 0.02, marking a decrease of 0.27.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness